Home
Biotechnology Value Fund reported a 22.3% stake in MoonLake Immunotherapeutics MLTX · 16,001,284 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 22.3%
- Last report
- 27.7% · filed 25/11/10
- Shares held
- 16,001,284 sh
- Class
- Class A ordinary share, par value $0.0001 per share
- Holder
- Biotechnology Value Fund
- Event date
- 26/03/31
- Filed
- 26/04/02
22.3% stake · −5.4pp from the last report
- Stake
- 22.3%
- Last report
- 27.7%
- Since last report
- −5.4pp
MoonLake Immunotherapeutics trades, last 26 weeks
What else happened in MoonLake Immunotherapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Biotechnology Value Fund's other 5% stake reports
- Biotechnology Value Fund
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.1% stake
4,215,886 sh
6.1% stake
Filed 09/21
- Biotechnology Value Fund
5% stakeAlector
5% stakeAlector
ALEC
8.4% stake
9,374,267 sh
8.4% stake
Filed 09/18
- Biotechnology Value Fund
5% stakePalvella Therapeutics
5% stakePalvella Therapeutics
PVLA
4.7% stake
672,789 sh
4.7% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
8% stake
3,235,778 sh
8% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeNektar Therapeutics
5% stakeNektar Therapeutics
NKTR
7.1% stake
2,391,075 sh
7.1% stake
Filed 08/14
